SCHEMBL6201675

SCHEMBL6201675

CN1CCCC[CH]C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825324 0.93
SCHEMBL1062964 0.82
SCHEMBL14940922 0.76 INMT (0.35)
SCHEMBL8305417 0.70
SCHEMBL4275496 0.68
SCHEMBL8272670 0.68 BRD4 (0.52)
SCHEMBL6201529 0.67 BRD4 (0.31)
SCHEMBL11059550 0.66 MEN1 (0.39)
SCHEMBL2143186 0.66 HSD17B10 (0.33)
SCHEMBL6201201 0.65 BRD4 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4463177-A Process for making m-hydroxyphenyl substituted compounds JOHN WYETH & BROTHER LIMITED (GB) 1984-07-31 US claimed
EP-1165532-B1 ANTIBACTERIAL AGENTS VERNALIS OXFORD LTD (GB) 2005-01-12 EP disclosed
US-6503897-B1 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2003-01-07 US disclosed
EP-1165532-A1 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2002-01-02 EP disclosed
WO-2000058294-A1 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-10-05 WO disclosed